These compounds exhibit a variety of actions and can influence key pathogenetic mechanisms: reducing steatosis by regulating lipogenesis, reducing inflammation through effects on hepatokines such as fetuin A, FGF21, and LECT2, improving gastrointestinal barrier function and microbiota composition, and suppressing oxidative stress and fibrosis. This evidence concerns the gene FGF21 and steatosis.